We showed that the platelet‐stored FXa could be released upon platelet activation at injury sites, and ameliorate bleeding disorders of HA and HB mice, especially the mice developed FVIII and FIX inhibitors, respectively. The gene discussed is F10; the disease is hemorrhagic disease.